Novo Nordisk drops its lawsuit against Hims & Hers as the companies partner to offer FDA-approved Wegovy and Ozempic through the telehealth platform.
A legal fight between Novo Nordisk and Hims & Hers Health has quickly turned into a business partnership.
The drugmaker has agreed to dismiss its patent lawsuit after the two companies struck a deal to sell popular weight-loss medicines through the t… [2906 chars]
Source: International Business Times | Published: 2026-03-10T11:54:09Z
Credit: International Business Times
